STUDY PERIOD
Start date: February 20, 2022
End date: October 31, 2023
STUDY INFORMATION
Indication: This study is developed to test safety and efficacy of SARS-CoV-2 vaccine in healthy adults.
Frequency of Visit:
In Person Visit: 7
Phone Calls: 9
STUDY CRITERIA
Age: 18 and older
Gender: Both
